YM17E
CAS No. 124900-72-7
YM17E ( —— )
Catalog No. M26512 CAS No. 124900-72-7
YM17E is an inhibitor of ACAT with IC50 of 44 nM in rabbit liver microsomes in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 101 | Get Quote |
|
10MG | 141 | Get Quote |
|
25MG | 235 | Get Quote |
|
50MG | 347 | Get Quote |
|
100MG | 518 | Get Quote |
|
500MG | 1134 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameYM17E
-
NoteResearch use only, not for human use.
-
Brief DescriptionYM17E is an inhibitor of ACAT with IC50 of 44 nM in rabbit liver microsomes in vitro.
-
DescriptionYM17E is an inhibitor of ACAT with IC50 of 44 nM in rabbit liver microsomes in vitro.(In Vitro):YM17E is potent in inhibiting ACAT activity in the intestine with IC50 of 34 nM.(In Vivo):YM17E inhibits the production of [14C]cholesteryloleate from [14C]oleoyl CoA in a dose-dependent manner in both liver and intestinal microsomes used as enzyme sources. YM17E (3, 5, 10 mg/kg, i.v.) significantly inhibits hepatic ACAT activities in a dose-dependent manner. YM17E (oral; i.v.) produces a significant increase in 125I-LDL clearance in atherogenic diet-fed rats. YM17E (3, 10, 30 mg/kg; p.o.) decreases total cholesterol, cholesteryl ester, and non-HDL cholesterol in a dose-dependent manner. YM17E (oral) decreases total cholesterol and cholesteryl ester levels in the liver significantly in a dose-dependent manner.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorHCV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number124900-72-7
-
Formula Weight652.9
-
Molecular FormulaC40H56N6O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN(C)c1ccc(NC(=O)N(Cc2cccc(CN(C3CCCCCC3)C(=O)Nc3ccc(cc3)N(C)C)c2)C2CCCCCC2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Makonen Belema, et al. Hepatitis C virus inhibitors. US8329159B2.
molnova catalog
related products
-
PAT-1251
PAT-1251 (PAT 1251, PAT1251) is apotent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays.
-
[2-(4-Chlorophenyl)-...
[2-(4-Chlorophenyl)-1,3-thiazol-4-yl]acetic acid?is an anti-inflammatory thiazole.
-
L-2-Phosphoglyceric ...
2-Phosphoglyceric acid (2PGA) is a glyceric acid which serves as the substrate in the ninth step of glycolysis. It is catalyzed by enolase into phosphoenolpyruvate (PEP) the penultimate step in the conversion of glucose to pyruvate.